Tianshui Zhongxing Bio-technology Co.,Ltd. (SHE:002772)
China flag China · Delayed Price · Currency is CNY
10.24
+0.32 (3.23%)
Jul 31, 2026, 3:04 PM CST

SHE:002772 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,8581,4501,1911,0391,3261,595
Trading Asset Securities
347.45353.06325.48285369.51263.43
Cash & Short-Term Investments
2,2061,8031,5171,3241,6961,859
Cash Growth
28.82%18.87%14.60%-21.95%-8.77%-2.36%
Accounts Receivable
36.9743.2436.0627.2440.9917.88
Other Receivables
2.696.852.561.041.743.73
Receivables
39.6550.0938.6228.2942.7321.6
Inventory
1,6031,5171,2521,2751,2551,174
Other Current Assets
33.3932.9422.5732.7742.9424.42
Total Current Assets
3,8813,4032,8302,6593,0373,079
Property, Plant & Equipment
3,1823,0052,7832,9433,0743,005
Long-Term Investments
155.51158.61136.7105.9484.3392.55
Other Intangible Assets
359.49359.14341.52334.38342.38350.59
Long-Term Accounts Receivable
-2.02---4.51
Long-Term Deferred Charges
7.743.220.350.050.190.34
Other Long-Term Assets
139.08158.8399.3431.1831.3519.34
Total Assets
7,7257,0896,1916,0746,5696,551

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
153.22189.93118.6179.08205.4155.57
Accrued Expenses
96.04129.16104.2799.2780.550.47
Short-Term Debt
302458.4615.46310.3150.16160
Current Portion of Long-Term Debt
825.04458.69694.67699.36830.2272.56
Current Portion of Leases
-2.50.010.010.010.01
Current Income Taxes Payable
9.151.21----
Current Unearned Revenue
4.565.094.875.115.496.62
Other Current Liabilities
180.01186.83176.35167.45171.69174.29
Total Current Liabilities
1,5701,4321,7141,4611,443819.53
Long-Term Debt
2,1511,8811,0591,0741,6222,353
Long-Term Leases
205.4588.480.260.270.280.29
Long-Term Unearned Revenue
128.48120.7598.24102.9118.51127.19
Other Long-Term Liabilities
32.1132.82----
Total Liabilities
4,0873,5552,8722,6383,1843,300

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
374.74393.24393.24393.24407.46407.42
Additional Paid-In Capital
1,9062,0272,0242,0242,0332,038
Retained Earnings
1,3541,2481,0251,015973.48854.42
Treasury Stock
--142.98-125.42--120-138.98
Comprehensive Income & Other
0.270.270.270.2787.987.99
Total Common Equity
3,6363,5263,3173,4323,3823,249
Minority Interest
2.288.491.613.043.072.53
Shareholders' Equity
3,6383,5343,3193,4363,3853,251
Total Liabilities & Equity
7,7257,0896,1916,0746,5696,551

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
3,4842,8892,3702,0842,6032,786
Net Cash (Debt)
-1,278-1,086-853.09-760.9-907.18-927.4
Net Cash Growth
------
Net Cash Per Share
-3.39-2.89-2.18-1.87-2.29-2.36
Filing Date Shares Outstanding
374.74374.74374.74393.24392.92392.89
Total Common Shares Outstanding
374.74374.74374.74393.24392.92392.89
Working Capital
2,3111,9711,1161,1991,5932,259
Book Value Per Share
9.709.418.858.738.618.27
Tangible Book Value
3,2763,1672,9763,0983,0392,898
Tangible Book Value Per Share
8.748.457.947.887.737.38
Buildings
-1,9811,7761,6771,5001,485
Machinery
-2,5462,4942,2622,0582,029
Construction In Progress
-404.02276.71503.08756.37467.85